Towards personalised management of atherosclerosis via computational models in vascular clinics: technology based on

Vanessa Díaz-Zuccarini1, Giulia Di Tomaso1, Obiekezie Agu2

  • 1UCL Mechanical Engineering , University College London , Multiscale Cardiovascular Engineering Group , Torrington Place , London , WC1E 7JE , UK.

Insights

This study introduces patient-specific computer simulations for personalized atherosclerosis healthcare. This technology aims to create in-silico management systems for better clinical support and patient outcomes.

Area of Science:

  • Biomedical Engineering
  • Computational Biology
  • Medical Simulation

Background:

  • Atherosclerosis is a leading global cause of death, presenting diverse clinical forms and imposing significant burdens on healthcare systems.
  • Its multifactorial, chronic, and lifelong nature creates substantial financial and clinical pressures.
  • Current healthcare approaches face challenges due to the complexity and systemic nature of the disease.

Purpose of the Study:

  • To present a novel technology for personalized healthcare in atherosclerosis using patient-specific modeling.
  • To explore the potential of computer simulations as in-silico management and support systems for chronic diseases.
  • To demonstrate a simulation workflow and an exemplar clinical application for atherosclerosis.

Main Methods:

  • Development of predictive models integrating diverse data (observations, theories, risk factors, anatomical sub-systems).
  • Combination of predictive models with digital patient data and advanced visualization tools.
  • Creation of a simulation workflow tailored to clinical requirements, exemplified by a vascular service unit.

Main Results:

  • A simulation workflow for patient-specific modeling in atherosclerosis has been established.
  • An exemplar application demonstrating the clinical utility of the developed technology is presented.
  • The technology is under development by a multidisciplinary team in collaboration with a clinical vascular unit.

Conclusions:

  • Patient-specific modeling and computer simulations hold significant promise for the future of personalized healthcare in managing complex diseases like atherosclerosis.
  • The developed in-silico approach can potentially alleviate clinical and financial pressures on healthcare systems.
  • Further development and clinical integration of this technology are ongoing to enhance patient care and management strategies.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
582
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
567
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
559
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
398
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
745
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
419